| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.08 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.09 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.09 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.09 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |